The role of nitric oxide synthase/ nitric oxide in infection-related cancers: Beyond antimicrobial activity.
Biochim Biophys Acta Rev Cancer
; 1879(5): 189156, 2024 Sep.
Article
em En
| MEDLINE
| ID: mdl-39032540
ABSTRACT
As a free radical and endogenous effector molecule, mammalian endogenous nitric oxide (NO) is mainly derived from nitric oxide synthase (NOS) via L-arginine. NO participates in normal physiological reactions and provides immune responses to prevent the invasion of foreign bacteria. However, NO also has complex and contradictory biological effects. Abnormal NO signaling is involved in the progression of many diseases, such as cancer. In the past decades, cancer research has been closely linked with NOS/ NO, and many tumors with poor prognosis are associated with high expression of NOS. In this review, we give a overview of the biological effects of NOS/ NO. Then we focus on the oncogenic role of iNOS/ NO in HPV, HBV, EBV and H. pylori related tumors. In fact, there is growing evidence that iNOS could be used as a potential therapeutic target in cancer therapy. We emphasize that the pro-tumor effect of NOS/ NO is greater than the anti-tumor effect.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias
/
Óxido Nítrico
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Biochim Biophys Acta Rev Cancer
/
Biochim. biophys. acta, Rev. cancer (Online)
/
Biochimica et biophysica acta. Reviews on cancer (Online)
Ano de publicação:
2024
Tipo de documento:
Article
País de publicação:
Holanda